{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:26:09Z","timestamp":1784010369301,"version":"3.55.0"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2017YFA0506000"],"award-info":[{"award-number":["2017YFA0506000"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770261"],"award-info":[{"award-number":["81770261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900233"],"award-info":[{"award-number":["81900233"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bcp.2021.114661","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T06:17:45Z","timestamp":1624429065000},"page":"114661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload"],"prefix":"10.1016","volume":"190","author":[{"given":"Yaguang","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ajoolabady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie J.","family":"Demillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3199-7793","authenticated-orcid":false,"given":"Michelle L.","family":"Hilaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-0783","authenticated-orcid":false,"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114661_b0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.freeradbiomed.2018.08.010","article-title":"Mechanisms of cardiac iron homeostasis and their importance to heart function","volume":"133","author":"Lakhal-Littleton","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2021.114661_b0010","first-page":"300","article-title":"Iron and heart failure: diagnosis, therapies, and future directions","volume":"5","author":"Ghafourian","year":"2020","journal-title":"Bas. Translat. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2021.114661_b0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10741-019-09788-z","article-title":"Influence of mitochondrial and systemic iron levels in heart failure pathology","volume":"24","author":"Lupu","year":"2019","journal-title":"Heart Fail. Rev."},{"issue":"12","key":"10.1016\/j.bcp.2021.114661_b0020","doi-asserted-by":"crossref","first-page":"21613","DOI":"10.1002\/jcp.28820","article-title":"Iron and the heart: A paradigm shift from systemic to cardiomyocyte abnormalities","volume":"234","author":"Paterek","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0025","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13324","article-title":"Keeping heart homeostasis in check through the balance of iron metabolism","volume":"228","author":"Vela","year":"2020","journal-title":"Acta Physiol (Oxf)"},{"issue":"3","key":"10.1016\/j.bcp.2021.114661_b0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/CS20040278","article-title":"Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration","volume":"109","author":"Dong","year":"2005","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"10.1016\/j.bcp.2021.114661_b0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00439-004-1166-y","article-title":"Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload","volume":"115","author":"Zaahl","year":"2004","journal-title":"Hum. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0040","first-page":"47","article-title":"Secondary iron overload","volume":"2001","author":"Kushner","year":"2001","journal-title":"ASH Education Program Book"},{"issue":"17","key":"10.1016\/j.bcp.2021.114661_b0045","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.2018893099","article-title":"Lobe specificity of iron binding to transferrin modulates murine erythropoiesis and iron homeostasis","volume":"134","author":"Parrow","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bcp.2021.114661_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.118535","article-title":"Iron homeostasis and oxidative stress: An intimate relationship","volume":"1866","author":"Galaris","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Res."},{"key":"10.1016\/j.bcp.2021.114661_b0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.redox.2017.11.026","article-title":"Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage","volume":"15","author":"DeGregorio-Rocasolano","year":"2018","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10735-020-09926-0","article-title":"Transferrin improved the generation of cardiomyocyte from human pluripotent stem cells for myocardial infarction repair","volume":"52","author":"Zhang","year":"2021","journal-title":"J. Mol. Histol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114661_b0065","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/dc11-0416","article-title":"Elevated transferrin saturation and risk of diabetes: three population-based studies","volume":"34","author":"Ellervik","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.bcp.2021.114661_b0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1373\/clinchem.2010.156802","article-title":"Total mortality by transferrin saturation levels: two general population studies and a metaanalysis","volume":"57","author":"Ellervik","year":"2011","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2021.114661_b0075","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3324\/haematol.2012.072314","article-title":"ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders","volume":"98","author":"Nam","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.bcp.2021.114661_b0080","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-2828(03)00072-5","article-title":"Differential accumulation of non-transferrin-bound iron by cardiac myocytes and fibroblasts","volume":"35","author":"Liu","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2021.114661_b0085","first-page":"157","article-title":"Myocardial release of non-transferrin-bound iron during cardio-pulmonary bypass surgery","volume":"30","author":"Ambrus","year":"1999","journal-title":"J. Med."},{"issue":"7","key":"10.1016\/j.bcp.2021.114661_b0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4330\/wjc.v3.i7.215","article-title":"Calcium channels and iron uptake into the heart","volume":"3","author":"Chattipakorn","year":"2011","journal-title":"World journal of cardiology"},{"issue":"11","key":"10.1016\/j.bcp.2021.114661_b0095","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.RES.84.11.1302","article-title":"Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload","volume":"84","author":"Tsushima","year":"1999","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.bcp.2021.114661_b0100","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","article-title":"L-type Ca 2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy","volume":"9","author":"Oudit","year":"2003","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bcp.2021.114661_b0105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0609.2010.01549.x","article-title":"T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice","volume":"86","author":"Kumfu","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcp.2021.114661_b0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000457143","article-title":"Acute effects of iron on contractile function in isolated rabbit myocardium","volume":"7","author":"Artman","year":"1984","journal-title":"Dev. Pharmacol. Therapeut."},{"issue":"2","key":"10.1016\/j.bcp.2021.114661_b0115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jmri.25396","article-title":"Left atrial active contractile function parameters assessed by cardiac MR are sensitive to myocardial iron","volume":"45","author":"Wehbe","year":"2017","journal-title":"J. Magn. Reson. Imaging"},{"issue":"10","key":"10.1016\/j.bcp.2021.114661_b0120","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s11064-007-9313-1","article-title":"Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures","volume":"32","author":"Gaasch","year":"2007","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.bcp.2021.114661_b0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2005.01.003","article-title":"The iron exporter ferroportin\/Slc40a1 is essential for iron homeostasis","volume":"1","author":"Donovan","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2021.114661_b0130","doi-asserted-by":"crossref","DOI":"10.1111\/1440-1681.13500","article-title":"Targeting autophagy in neurodegenerative diseases: from molecular mechanisms to clinical therapeutics","author":"Ajoolabady","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bcp.2021.114661_b0135","article-title":"Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics","volume":"107848","author":"Ajoolabady","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2021.114661_b0140","article-title":"Enzyme-based autophagy in anti-neoplastic management: from molecular mechanisms to clinical therapeutics, Biochimica et Biophysica Acta (BBA)-Reviews on","author":"Ajoolabady","year":"2020","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2021.114661_b0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/ph11040114","article-title":"The role of NCOA4-mediated ferritinophagy in health and disease","volume":"11","author":"Santana-Codina","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bcp.2021.114661_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.tem.2021.04.010","article-title":"Ferritinophagy and ferroptosis in the management of metabolic diseases","author":"Ajoolabady","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.bcp.2021.114661_b0155","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nchembio807","article-title":"The role of iron regulatory proteins in mammalian iron homeostasis and disease","volume":"2","author":"Rouault","year":"2006","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114661_b0160","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","article-title":"Systemic iron homeostasis","volume":"93","author":"Ganz","year":"2013","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2021.114661_b0165","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000035","article-title":"Erythroferrone: an erythroid regulator of hepcidin and iron metabolism","volume":"2","author":"Coffey","year":"2018","journal-title":"HemaSphere"},{"issue":"4","key":"10.1016\/j.bcp.2021.114661_b0170","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1017\/S1368980008002401","article-title":"Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993\u20132005","volume":"12","author":"McLean","year":"2009","journal-title":"Public Health Nutr."},{"issue":"5","key":"10.1016\/j.bcp.2021.114661_b0175","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1182\/blood-2013-06-508325","article-title":"A systematic analysis of global anemia burden from 1990 to 2010","volume":"123","author":"Kassebaum","year":"2014","journal-title":"Blood"},{"issue":"29","key":"10.1016\/j.bcp.2021.114661_b0180","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.3748\/wjg.v20.i29.10024","article-title":"Capsule endoscopy: Present status and future expectation","volume":"20","author":"Goenka","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"9","key":"10.1016\/j.bcp.2021.114661_b0185","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrcardio.2011.77","article-title":"Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches","volume":"8","author":"Van Veldhuisen","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"issue":"15","key":"10.1016\/j.bcp.2021.114661_b0190","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.bcp.2021.114661_b0195","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients, Circulation","volume":"11","author":"Grote Beverborg","year":"2018","journal-title":"Heart Failure"},{"issue":"36","key":"10.1016\/j.bcp.2021.114661_b0200","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","article-title":"Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure","volume":"35","author":"Jankowska","year":"2014","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0205","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bcp.2021.114661_b0210","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/ejhf.1781","article-title":"Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fraction","volume":"22","author":"Hirsch","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bcp.2021.114661_b0215","doi-asserted-by":"crossref","unstructured":"G. Mi\u00f1ana, E. Santas, R. de la Espriella, E. N\u00fa\u00f1ez, M. Lorenzo, G. N\u00fa\u00f1ez, E. Valero, V. Bod\u00ed, F.J. Chorro, J. Sanchis, Right ventricular function and iron deficiency in acute heart failure, Europ. Heart J. Acute Cardiovasc. Care (2020).","DOI":"10.1093\/ehjacc\/zuaa028"},{"key":"10.1016\/j.bcp.2021.114661_b0220","doi-asserted-by":"crossref","unstructured":"H. Zhang, K. Jamieson, J. Grenier, A. Nikhanj, J. Tang, Q. Nguyen, S. Wang, R. Thompson, J. Seubert, G. Oudit, Myocardial iron depletion exacerbates end-stage heart failure by promoting adverse remodeling and worsening mitochondrial function, Eur. Heart J. 41(Supplement_2) (2020) ehaa946. 1144.","DOI":"10.1093\/ehjci\/ehaa946.1144"},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0225","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001153","article-title":"Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study","volume":"7","author":"Beattie","year":"2020","journal-title":"Open heart"},{"issue":"5","key":"10.1016\/j.bcp.2021.114661_b0230","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cardfail.2020.03.004","article-title":"Increased iron absorption in patients with chronic heart failure and iron deficiency","volume":"26","author":"Cabrera","year":"2020","journal-title":"J. Cardiac Fail."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/HYPERTENSIONAHA.116.07307","article-title":"Inflammation in heart failure: the holy grail?","volume":"68","author":"Mehta","year":"2016","journal-title":"Hypertension"},{"issue":"9586","key":"10.1016\/j.bcp.2021.114661_b0240","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0140-6736(07)61235-5","article-title":"Nutritional iron deficiency","volume":"370","author":"Zimmermann","year":"2007","journal-title":"The lancet"},{"issue":"3","key":"10.1016\/j.bcp.2021.114661_b0245","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4291\/wjgp.v6.i3.62","article-title":"Iron deficiency anemia in inflammatory bowel disease","volume":"6","author":"Kaitha","year":"2015","journal-title":"World J Gastrointest. Pathophysiol."},{"issue":"22","key":"10.1016\/j.bcp.2021.114661_b0250","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3748\/wjg.v16.i22.2720","article-title":"Treatment of iron deficiency anemia associated with gastrointestinal tract diseases","volume":"16","author":"Bayraktar","year":"2010","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"8","key":"10.1016\/j.bcp.2021.114661_b0255","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10554-009-9491-9","article-title":"Effect of iron overload on exercise capacity in thalassemic patients with heart failure","volume":"25","author":"Mavrogeni","year":"2009","journal-title":"Int. J. Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1532-429X-13-23","article-title":"Iron overload in polytransfused patients without heart failure is associated with subclinical alterations of systolic left ventricular function using cardiovascular magnetic resonance tagging","volume":"13","author":"Seldrum","year":"2011","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"6","key":"10.1016\/j.bcp.2021.114661_b0265","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.cardfail.2009.06.306","article-title":"The role of autophagy in iron-overload cardiomyopathy: a model of diastolic heart failure due to oxidative stress","volume":"15","author":"Li","year":"2009","journal-title":"J. Cardiac Fail."},{"issue":"21","key":"10.1016\/j.bcp.2021.114661_b0270","doi-asserted-by":"crossref","first-page":"R1292","DOI":"10.1016\/j.cub.2020.09.068","article-title":"Ferroptosis","volume":"30","author":"Tang","year":"2020","journal-title":"Curr. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114661_b0275","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2021.114661_b0280","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","article-title":"Emerging mechanisms and disease relevance of ferroptosis","volume":"30","author":"Stockwell","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0285","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2018.02.061","article-title":"Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis","volume":"497","author":"Liu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2021.114661_b0290","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.freeradbiomed.2020.08.009","article-title":"Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury","volume":"160","author":"Li","year":"2020","journal-title":"Free Radical Biol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0295","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbrc.2019.06.015","article-title":"Role of TLR4\/NADPH oxidase 4 pathway in promoting cell death through autophagy and ferroptosis during heart failure","volume":"516","author":"Chen","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2021.114661_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2011.05.021","article-title":"Prevalence of Iron Deficiency Screening in Patients with Acute Myocardial Infarction Who Develop Hospital-Acquired Anemia","author":"Salisbury","year":"2011","journal-title":"Am Heart Assoc"},{"issue":"suppl_1","key":"10.1016\/j.bcp.2021.114661_b0305","first-page":"A18474","article-title":"Iron deficiency independently and strongly predicts risk of cardiovascular death and myocardial infarction in patients with acute coronary syndrome","volume":"134","author":"Karakas","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2021.114661_b0310","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2019.07.083","article-title":"Iron deficiency in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"300","author":"Cosentino","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bcp.2021.114661_b0315","doi-asserted-by":"crossref","unstructured":"J. Costa, H. Mesrar, L. Chapoutot, B. Maillier, D. Metz, Prevalence and prognosis of iron deficiency in acute myocardial infarction, Arch. Cardiovasc. Dis. Suppl. 13(1) 8.","DOI":"10.1016\/j.acvdsp.2020.10.007"},{"key":"10.1016\/j.bcp.2021.114661_b0320","doi-asserted-by":"crossref","unstructured":"J. Barrabes, D. Aluja, L. Castellote, A. Rodriguez, I. Otaegi, V. Pineda, A. Mila, J. Baneras, R. Lidon, A. Sambola, Iron deficiency is associated with larger infarcts and with adverse remodeling in STEMI patients and reduces myocardial tolerance to ischemia\/reperfusion by inhibiting the eNOS\/sGC\/PKG pathway in mice, Eur. Heart J. 41(Supplement_2) (2020) ehaa946. 1578.","DOI":"10.1093\/ehjci\/ehaa946.1578"},{"key":"10.1016\/j.bcp.2021.114661_b0325","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2015.07.056","article-title":"Role of Non-Transferrin-Bound Iron in the pathogenesis of cardiotoxicity in patients with ST-elevation myocardial infarction assessed by Cardiac Magnetic Resonance Imaging","volume":"199","author":"Roghi","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114661_b0330","first-page":"1248","article-title":"Persistent iron within the infarct core after ST-segment elevation myocardial infarction: implications for left ventricular remodeling and health outcomes","volume":"11","author":"Carberry","year":"2018","journal-title":"JACC: Cardiovascul. Imag."},{"issue":"10","key":"10.1016\/j.bcp.2021.114661_b0335","article-title":"Residual myocardial iron following intramyocardial hemorrhage during the convalescent phase of reperfused ST-segment\u2013elevation myocardial infarction and adverse left ventricular remodeling, Circulation","volume":"9","author":"Bulluck","year":"2016","journal-title":"Cardiovasc. Imag."},{"issue":"11S","key":"10.1016\/j.bcp.2021.114661_b0340","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0735-1097(17)33586-6","article-title":"Myocardial hemorrhage after coronary ischemia-reperfusion leads to an iron-mediated, self-perpetuating loop of foam cell and ceroid accumulation","volume":"69","author":"Cokic","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114661_b0345","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4070\/kcj.2008.38.7.360","article-title":"Detection of Transferrin Receptor Over-Expression in a Rodent Model of Myocardial Ischemia\/Reperfusion Injury Using Novel 99mTc Transferrin Conjugates: A Pilot Study","volume":"38","author":"Jeong","year":"2008","journal-title":"Korean Circul. J."},{"issue":"11","key":"10.1016\/j.bcp.2021.114661_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-2061-8","article-title":"Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes","volume":"10","author":"Park","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2021.114661_b0355","first-page":"1","article-title":"Human umbilical cord blood\u2013derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice","author":"Song","year":"2020","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bcp.2021.114661_b0360","doi-asserted-by":"crossref","unstructured":"P. Franczuk, A. Kosiorek, M. Tkaczyszyn, M. Drozd, A. Zapolska, T. Walczak, K. Kulej-Lyko, N. Sidorowicz, A. Soltowska, W. Banasiak, P754 Iron status indices (transferrin saturation, serum ferritin) in the course of acute myocarditis: relations with neurohormonal activation, cardiac dysfunction and clinical recovery, Eur. Heart J. 40(Supplement_1) (2019) ehz747. 0356.","DOI":"10.1093\/eurheartj\/ehz747.0356"},{"key":"10.1016\/j.bcp.2021.114661_b0365","doi-asserted-by":"crossref","unstructured":"W. Kosmala, P. Franczuk, E. Jasic-Szpak, M. Tkaczyszyn, M. Drozd, N. Sidorowicz, K. Kulej-Lyko, T. Walczak, A. Zapolska, M. Przewlocka-Kosmala, P1392 Association of iron deficiency with left ventricular longitudinal function abnormalities in patients with acute myocarditis, Eur. Heart J.-Cardiovas. Imag. 21(Supplement_1) (2020) jez319. 825.","DOI":"10.1093\/ehjci\/jez319.825"},{"key":"10.1016\/j.bcp.2021.114661_b0370","doi-asserted-by":"crossref","unstructured":"K. Kobak, J. Schubert, M. Kasztura, P. Franczuk, M. Dziegala, M. Drozd, M. Tkaczyszyn, K. Kulej-Lyko, J. Bania, W. Banasiak, P6353 Iron depletion in human cardiomyocytes cultured with sera from myocarditis patients, Eur. Heart J. 40(Supplement_1) (2019) ehz746. 0949.","DOI":"10.1093\/eurheartj\/ehz746.0949"},{"key":"10.1016\/j.bcp.2021.114661_b0375","doi-asserted-by":"crossref","unstructured":"K. Kobak, M. Dziegala, P. Franczuk, M. Kasztura, M. Tkaczyszyn, M. Drozd, K. Josiak, N. Sidorowicz, P. Gac, L. Kiczak, P920 The influence of iron status on the impaired functioning of human cardiofibroblasts and cardiomyocytes in the course of acute phase of myocarditis, Eur. Heart J. 39(suppl_1) (2018) ehy564. P920.","DOI":"10.1093\/eurheartj\/ehy564.P920"},{"key":"10.1016\/j.bcp.2021.114661_b0380","article-title":"Aggravation of Cardiac Injury by Iron and Heme Oxygenase-1 in Viral Myocarditis","author":"Klingel","year":"2012","journal-title":"Am. Heart Assoc."},{"key":"10.1016\/j.bcp.2021.114661_b0385","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijcard.2014.10.006","article-title":"Bone marrow iron depletion is common in patients with coronary artery disease","volume":"182","author":"Jankowska","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.bcp.2021.114661_b0390","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3345\/kjp.2018.06905","article-title":"Iron deficiency anemia as a predictor of coronary artery abnormalities in Kawasaki disease","volume":"62","author":"Kim","year":"2019","journal-title":"Kor. J. Pediatr."},{"issue":"2","key":"10.1016\/j.bcp.2021.114661_b0395","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.atherosclerosis.2014.12.018","article-title":"Iron status and its association with coronary heart disease: systematic review and meta-analysis of prospective studies","volume":"238","author":"De","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bcp.2021.114661_b0400","article-title":"Iron deficiency does not impair the outcome after elective coronary artery bypass and aortic valve procedures","author":"Immohr","year":"2020","journal-title":"J. Card. Surg."},{"key":"10.1016\/j.bcp.2021.114661_b0405","article-title":"Iron Deficiency as the Most Ominous Substrate for Anemia in Patients Undergoing Coronary Artery Bypass Surgery","author":"Weissert","year":"2011","journal-title":"Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.bcp.2021.114661_b0410","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.atherosclerosis.2014.07.002","article-title":"Hemoglobin, iron metabolism and angiographic coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study)","volume":"236","author":"Grammer","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bcp.2021.114661_b0415","doi-asserted-by":"crossref","unstructured":"R. Natesirinilkul, P. Charoenkwan, R. Sittiwangkul, S. Silvilairat, Y. Prongpot, Coronary Artery Thrombosis in an Infant with Kawasaki Disease without Giant Coronary Aneurysm and Iron Deficiency Anemia: a Case Report, Circulation 131(suppl_2) (2015) A206.","DOI":"10.1161\/circ.131.suppl_2.206"},{"issue":"28","key":"10.1016\/j.bcp.2021.114661_b0420","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/eurheartj\/ehz112","article-title":"Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction","volume":"41","author":"Vinchi","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2021.114661_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116702","article-title":"Chronic iron overload intensifies atherosclerosis in apolipoprotein E deficient mice: Role of oxidative stress and endothelial dysfunction","volume":"233","author":"Marques","year":"2019","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.bcp.2021.114661_b0430","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.4155\/fmc.09.121","article-title":"Synthetic and natural iron chelators: therapeutic potential and clinical use","volume":"1","author":"Hatcher","year":"2009","journal-title":"Future Med. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2021.114661_b0435","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00380-020-01613-0","article-title":"The effects of serum iron level without anemia on long-term prognosis of patients with coronary heart disease complicated with chronic heart failure: a retrospective cohort study","volume":"35","author":"Yan","year":"2020","journal-title":"Heart Vessels"},{"issue":"12","key":"10.1016\/j.bcp.2021.114661_b0440","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.2337\/dc13-0528","article-title":"Iron status and survival in diabetic patients with coronary artery disease","volume":"36","author":"Ponikowska","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.bcp.2021.114661_b0445","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1183\/09031936.00037711","article-title":"Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target","volume":"38","author":"Rhodes","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.bcp.2021.114661_b0450","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1183\/09031936.00100510","article-title":"Iron deficiency is common in idiopathic pulmonary arterial hypertension","volume":"37","author":"Ruiter","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"26","key":"10.1016\/j.bcp.2021.114661_b0455","doi-asserted-by":"crossref","first-page":"13122","DOI":"10.1073\/pnas.1822010116","article-title":"Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension in mice","volume":"116","author":"Lakhal-Littleton","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2021.114661_b0460","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/thx.2010.147272","article-title":"Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertension","volume":"66","author":"Soon","year":"2011","journal-title":"Thorax"},{"issue":"11_Supplement_1","key":"10.1016\/j.bcp.2021.114661_b0465","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/S0735-1097(20)33958-9","article-title":"Iron overload cardiomyopathy with pulmonary hypertension and thalassemia syndrome","volume":"75","author":"Sesay","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114661_b0470","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.carpath.2014.09.006","article-title":"Chronic thromboembolic pulmonary hypertension is not associated with iron overload","volume":"24","author":"Xi","year":"2015","journal-title":"Cardiovasc. Pathol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114661_b0475","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ejcts\/ezw062","article-title":"Pulmonary endarterectomy is effective and safe in patients with haemoglobinopathies and abnormal red blood cells: the Papworth experience","volume":"50","author":"Mahesh","year":"2016","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.bcp.2021.114661_b0480","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.toxlet.2018.07.010","article-title":"Chronic iron overload induces vascular dysfunction in resistance pulmonary arteries associated with right ventricular remodeling in rats","volume":"295","author":"Bertoli","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"12","key":"10.1016\/j.bcp.2021.114661_b0485","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114661_b0490","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/ccr3.407","article-title":"Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy","volume":"3","author":"Pinto","year":"2015","journal-title":"Clinical case reports"},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0495","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12185-017-2373-3","article-title":"Modern iron replacement therapy: clinical and pathophysiological insights","volume":"107","author":"Girelli","year":"2018","journal-title":"Int. J. Hematol."},{"issue":"23","key":"10.1016\/j.bcp.2021.114661_b0500","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/01.CIR.103.23.2799","article-title":"Iron chelation improves endothelial function in patients with coronary artery disease","volume":"103","author":"Duffy","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2021.114661_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173999","article-title":"Combination of ponatinib with deferoxamine synergistically mitigates ischemic heart injury via simultaneous prevention of necroptosis and ferroptosis","author":"Tu","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114661_b0510","doi-asserted-by":"crossref","first-page":"H1656","DOI":"10.1152\/ajpheart.00041.2002","article-title":"Reactive oxygen species generated during myocardial ischemia enable energetic recovery during reperfusion","volume":"283","author":"Klawitter","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114661_b0515","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/03630269.2014.965781","article-title":"A systematic review and meta-analysis of deferiprone monotherapy and in combination with deferoxamine for reduction of iron overload in chronically transfused patients with \u03b2-thalassemia","volume":"38","author":"Kuo","year":"2014","journal-title":"Hemoglobin"},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0520","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/tme.12188","article-title":"Combination therapy\u2013deferasirox and deferoxamine\u2013in thalassemia major patients in emerging countries with limited resources","volume":"25","author":"Arandi","year":"2015","journal-title":"Transfusion Medicine"},{"issue":"9","key":"10.1016\/j.bcp.2021.114661_b0525","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2005-07-2933","article-title":"Cardiac morbidity and mortality in deferoxamine-or deferiprone-treated patients with thalassemia major","volume":"107","author":"Borgna-Pignatti","year":"2006","journal-title":"Blood"},{"issue":"Suppl_1","key":"10.1016\/j.bcp.2021.114661_b0530","doi-asserted-by":"crossref","first-page":"A848","DOI":"10.1161\/res.125.suppl_1.848","article-title":"The Iron Chelator Deferiprone Clears Hemorrhagic Byproducts Following Acute Myocardial Infarction in a Swine Model of Ischemia-Reperfusion","volume":"125","author":"Weyers","year":"2019","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1532-429X-15-83","article-title":"Right and left ventricular function and myocardial scarring in adult patients with sickle cell disease: a comprehensive magnetic resonance assessment of hepatic and myocardial iron overload","volume":"15","author":"Junqueira","year":"2013","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"5","key":"10.1016\/j.bcp.2021.114661_b0540","first-page":"795","article-title":"Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective","volume":"3","author":"Galanello","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0545","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cjce.23048","article-title":"Synthesis of nano-niosomal deferoxamine and evaluation of its functional characteristics to apply as an iron-chelating agent","volume":"96","author":"Marzban","year":"2018","journal-title":"Canad. J. Chem. Eng."},{"issue":"19","key":"10.1016\/j.bcp.2021.114661_b0550","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.bcp.2021.114661_b0555","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bcp.2021.114661_b0560","first-page":"1342","article-title":"2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can. J. Cardiol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114661_b0565","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrcardio.2015.109","article-title":"Iron deficiency and cardiovascular disease","volume":"12","author":"von Haehling","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114661_b0570","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia","volume":"168","author":"Beck-da-Silva","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114661_b0575","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/eurjhf\/hfq165","article-title":"Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial","volume":"12","author":"Gonz\u00e1lez-Costello","year":"2010","journal-title":"Eur. J. Heart Fail."},{"issue":"11","key":"10.1016\/j.bcp.2021.114661_b0580","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur. Heart J."},{"issue":"10266","key":"10.1016\/j.bcp.2021.114661_b0585","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.bcp.2021.114661_b0590","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/00015385.2019.1625554","article-title":"The importance of dose optimisation in the treatment of iron deficiency in heart failure","volume":"75","author":"Martens","year":"2020","journal-title":"Acta Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114661_b0595","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1139\/y90-068","article-title":"Transferrin delays oxygen radical induced cardiac-contractile failure","volume":"68","author":"Tiede","year":"1990","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114661_b0600","article-title":"Targeting Heme Oxygenase-1 in Cardiovascular and Kidney Disease","volume":"8","author":"Drummond","year":"2019","journal-title":"Antioxidants (Basel)"},{"issue":"14","key":"10.1016\/j.bcp.2021.114661_b0605","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1089\/ars.2019.7970","article-title":"Heme Oxygenase-1 Upregulation: A Novel Approach in the Treatment of Cardiovascular Disease","volume":"32","author":"Bellner","year":"2020","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0610","first-page":"13","article-title":"Heme oxygenase-1 in cardiovascular diseases: molecular mechanisms and clinical perspectives","volume":"33","author":"Wang","year":"2010","journal-title":"Chang Gung Med J"},{"issue":"15","key":"10.1016\/j.bcp.2021.114661_b0615","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.3390\/ijms20153628","article-title":"The protective role of heme oxygenase-1 in atherosclerotic diseases","volume":"20","author":"Kishimoto","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2021.114661_b0620","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00380-020-01733-7","article-title":"Subjects with coronary artery disease and reduced ejection fraction have longer (GT) n repeats in the heme-oxygenase 1 gene promoter","volume":"36","author":"Liang","year":"2021","journal-title":"Heart Vessels"},{"issue":"10","key":"10.1016\/j.bcp.2021.114661_b0625","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3390\/ijms20102427","article-title":"The role of heme oxygenase 1 in the protective effect of caloric restriction against diabetic cardiomyopathy","volume":"20","author":"Waldman","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2021.114661_b0630","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00018-019-03305-z","article-title":"Multifunctional nanomedicines for targeting epidermal growth factor receptor in colorectal cancer","volume":"77","author":"Khiavi","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.bcp.2021.114661_b0635","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2017.02.005","article-title":"Ferroptosis inhibition: mechanisms and opportunities","volume":"38","author":"Angeli","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"6014","key":"10.1016\/j.bcp.2021.114661_b0640","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1197203","article-title":"The structure of human 5-lipoxygenase","volume":"331","author":"Gilbert","year":"2011","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.bcp.2021.114661_b0645","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1021\/acschembio.7b00730","article-title":"The potency of diarylamine radical-trapping antioxidants as inhibitors of ferroptosis underscores the role of autoxidation in the mechanism of cell death","volume":"12","author":"Shah","year":"2017","journal-title":"ACS Chem. Biol."},{"issue":"18","key":"10.1016\/j.bcp.2021.114661_b0650","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1021\/cr500226n","article-title":"Advances in radical-trapping antioxidant chemistry in the 21st century: a kinetics and mechanisms perspective","volume":"114","author":"Ingold","year":"2014","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0655","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0660","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2021.114661_b0665","article-title":"Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP\/PS1 murine model of Alzheimer's disease via inhibition of ACSL4-dependent ferroptosis","author":"Zhu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0670","first-page":"67","article-title":"Comparative effect of pioglitazone, quercetin and hydroxy citric acid on the status of lipid peroxidation and antioxidants in experimental non-alcoholic steatohepatitis","volume":"65","author":"Surapaneni","year":"2014","journal-title":"J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114661_b0675","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1742-7843.2007.00113.x","article-title":"Amelioration of corticosteroid-induced type 2 diabetes mellitus by rosiglitazone is possibly mediated through stimulation of thyroid function and inhibition of tissue lipid peroxidation in mice","volume":"101","author":"Jatwa","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114661_b0680","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.HYP.36.3.430","article-title":"Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects","volume":"36","author":"Garg","year":"2000","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.bcp.2021.114661_b0685","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1191\/0960327106ht637oa","article-title":"Comparative study of the protective effect between deferoxamine and deferiprone on chronic iron overload induced cardiotoxicity in rats","volume":"25","author":"Emara","year":"2006","journal-title":"Hum. Exp. Toxicol."},{"issue":"8019","key":"10.1016\/j.bcp.2021.114661_b0690","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(77)92279-6","article-title":"Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine","volume":"309","author":"Hussain","year":"1977","journal-title":"The Lancet"},{"key":"10.1016\/j.bcp.2021.114661_b0695","first-page":"117","article-title":"Antioxidant and chelator cocktails to prevent oxidative stress under iron-overload conditions","author":"Kumfu","year":"2020","journal-title":"Pathology Elsevier"},{"key":"10.1016\/j.bcp.2021.114661_b0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173513","article-title":"L-type calcium channel blockers decrease the iron overload-mediated oxidative stress in renal epithelial cells by reducing iron accumulation","volume":"886","author":"Sun","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114661_b0705","article-title":"Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia","volume":"7","author":"Sadaf","year":"2018","journal-title":"Cochrane Datab. Systemat. Rev."},{"issue":"Suppl_1","key":"10.1016\/j.bcp.2021.114661_b0710","first-page":"A15973","article-title":"Ebselen, a Divalent Metal Transporter 1 Inhibitor, Effectively Blocks Iron Entry to Human Ipsc-Derived Cardiomyocytes and Prevents Iron-Overload Cardiotoxicity","volume":"140","author":"Rhee","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2021.114661_b0715","doi-asserted-by":"crossref","unstructured":"C. Casu, A. Goldberg, E. Nemeth, T. Ganz, S. Gardenghi, B. MacDonald, S. Rivella, Treatment with minihepcidin peptide improves anemia and iron overload in a mouse model of thalassemia intermedia, American Society of Hematology Washington, DC, 2013.","DOI":"10.1182\/blood.V122.21.431.431"},{"key":"10.1016\/j.bcp.2021.114661_b0720","doi-asserted-by":"crossref","unstructured":"F. B\u00e9liveau, A. Tarkar, S.P. Dion, A. D\u00e9silets, M.G. Ghinet, P.-L. Boudreault, C. St-Georges, \u00c9. Marsault, D. Paone, J. Collins, Discovery and development of TMPRSS6 inhibitors modulating hepcidin levels in human hepatocytes, Cell Chem. Biol. 26(11) (2019) 1559-1572. e9.","DOI":"10.1016\/j.chembiol.2019.09.004"},{"key":"10.1016\/j.bcp.2021.114661_b0725","article-title":"Tmprss6, An Inhibitor of Hepatic Bmp\/Smad Signaling, Is Required for Hepcidin Suppression and Iron Loading In a Mouse Model of \u03b2-Thalassemia, American Society of","author":"Finberg","year":"2010","journal-title":"Hematology"},{"key":"10.1016\/j.bcp.2021.114661_b0730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15226514.2020.1857332","article-title":"Selective removal of iron (III), lead (II) and copper (II) ions by polar crude phytochemicals recovered from ten South African plants: identification of plant phytochemicals","author":"Tanui","year":"2020","journal-title":"Int. J. Phytorem."},{"key":"10.1016\/j.bcp.2021.114661_b0735","doi-asserted-by":"crossref","unstructured":"S. Lane, J. Ehlting, P.B. Walter, Iron-Chelating Potential of Novel Phytochemicals in Poplar and Cedar Trees, American Society of Hematology Washington, DC, 2019.","DOI":"10.1182\/blood-2019-127259"},{"issue":"7","key":"10.1016\/j.bcp.2021.114661_b0740","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.bbadis.2018.08.030","article-title":"Role of iron metabolism in heart failure: From iron deficiency to iron overload","volume":"1865","author":"Zhang","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0745","first-page":"36","article-title":"Iron deficiency in heart failure: an overview, JACC","volume":"7","author":"von Haehling","year":"2019","journal-title":"Heart Failure"},{"issue":"10","key":"10.1016\/j.bcp.2021.114661_b0750","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00109-010-0663-9","article-title":"Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease","volume":"88","author":"Ren","year":"2010","journal-title":"J Mol. Med (Berl)"},{"key":"10.1016\/j.bcp.2021.114661_b0755","article-title":"Mitophagy Receptors and Mediators: Therapeutic Targets in the Management of Cardiovascular Ageing","volume":"101129","author":"Ajoolabady","year":"2020","journal-title":"Age. Res. Rev."},{"issue":"38","key":"10.1016\/j.bcp.2021.114661_b0760","doi-asserted-by":"crossref","first-page":"eabc8561","DOI":"10.1126\/sciadv.abc8561","article-title":"FUNDC1 interacts with FBXL2 to govern mitochondrial integrity and cardiac function through an IP3R3-dependent manner in obesity","volume":"6","author":"Ren","year":"2020","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.bcp.2021.114661_b0765","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.celrep.2015.09.023","article-title":"Lethal cardiomyopathy in mice lacking transferrin receptor in the heart","volume":"13","author":"Xu","year":"2015","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.bcp.2021.114661_b0770","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ejhf.1154","article-title":"Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function","volume":"20","author":"Hoes","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bcp.2021.114661_b0775","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8885189","article-title":"Accurate Noninvasive Assessment of Myocardial Iron Load in Advanced Heart Failure Patients","volume":"2020","author":"Leszek","year":"2020","journal-title":"Dis. Markers"},{"issue":"3","key":"10.1016\/j.bcp.2021.114661_b0780","first-page":"269","article-title":"Pathogenesis of cardiac hypertrophy in iron deficiency anaemia: the role of noradrenaline","volume":"63","author":"Rossi","year":"1982","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.bcp.2021.114661_b0785","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fnmol.2019.00007","article-title":"Noradrenaline acting on alpha1 adrenoceptor as well as by chelating iron reduces oxidative burden on the brain: implications with rapid eye movement sleep","volume":"12","author":"Singh","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2021.114661_b0790","article-title":"High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality","author":"Sierpinski","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.bcp.2021.114661_b0795","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bcp.2021.114661_b0800","first-page":"1130","article-title":"Cellular iron uptake, trafficking and metabolism: key molecules and mechanisms and their roles in disease, Biochimica et Biophysica Acta (BBA)-Molecular","volume":"1853","author":"Lane","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2021.114661_b0805","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnab006","article-title":"ER stress in cardiometabolic diseases: from molecular mechanisms to therapeutics","author":"Ajoolabady","year":"2021","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2021.114661_b0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2021.114661_b0815","first-page":"1","article-title":"Ferroptosis: molecular mechanisms and health implications","author":"Tang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2021.114661_b0820","first-page":"1","article-title":"Ferroptosis: machinery and regulation","author":"Chen","year":"2020","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.bcp.2021.114661_b0825","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Angeli","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2021.114661_b0830","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-019-09815-z","article-title":"Iron deficiency as therapeutic target in heart failure: a translational approach","volume":"25","author":"Bakogiannis","year":"2020","journal-title":"Heart Fail. Rev."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221002744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221002744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:30:55Z","timestamp":1757770255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221002744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":166,"alternative-id":["S0006295221002744"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114661","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114661"}}